1069 related articles for article (PubMed ID: 9557617)
21. Adult T-cell leukemia/lymphoma clinically confused with viral/drug skin eruptions and pathologically misinterpreted as mycosis fungoides/Sézary syndrome.
AbdullGaffar B; Abdulrahman S
J Cutan Pathol; 2021 Sep; 48(9):1103-1108. PubMed ID: 33354782
[TBL] [Abstract][Full Text] [Related]
22. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
23. Evidence for the cofactor role of human T-cell lymphotropic virus type 1 in mycosis fungoides and Sézary syndrome.
Shohat M; Hodak E; Hannig H; Bodemer W; David M; Shohat B
Br J Dermatol; 1999 Jul; 141(1):44-9. PubMed ID: 10417514
[TBL] [Abstract][Full Text] [Related]
24. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
[TBL] [Abstract][Full Text] [Related]
25. Adult T-cell leukemia/lymphoma and cutaneous T-cell lymphoma. Are they related?
Yamada M; Takigawa M; Iwatsuki K; Inoue F
Int J Dermatol; 1989 Mar; 28(2):107-13. PubMed ID: 2786860
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous T cell lymphoma differing from classical mycosis fungoides and Sézary syndrome: clinical, histological and immunohistochemical studies of six cases.
Maeda K; Takahashi M; Takatsuka N; Miyazawa H
J Dermatol; 1990 Apr; 17(4):226-34. PubMed ID: 2195088
[TBL] [Abstract][Full Text] [Related]
27. Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
Jiang TT; Cao S; Kruglov O; Virmani A; Geskin LJ; Falo LD; Akilov OE
J Invest Dermatol; 2024 May; 144(5):1088-1098. PubMed ID: 38036289
[TBL] [Abstract][Full Text] [Related]
28. A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma.
Vonderheid EC; Kantor GR; Telang GH; Bujanouskas P; Kadin ME
J Cutan Pathol; 2019 Dec; 46(12):913-924. PubMed ID: 31403211
[TBL] [Abstract][Full Text] [Related]
29. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.
Kawana Y; Suga H; Kamijo H; Miyagaki T; Sugaya M; Sato S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830466
[TBL] [Abstract][Full Text] [Related]
30. Anti-V region antibodies as "almost clonotypic" reagents for the study of cutaneous T cell lymphomas and leukemias.
Charley M; McCoy JP; Deng JS; Jegasothy B
J Invest Dermatol; 1990 Nov; 95(5):614-7. PubMed ID: 2146326
[TBL] [Abstract][Full Text] [Related]
31. [Rare variants of cutaneous T-cell lymphomas].
Goerdt S; Trautmann C; Kütting B; Ramaker J; Schmuth M; Thiel E; Luger T; Stein H; Orfanos CE
Hautarzt; 1996 Feb; 47(2):96-105. PubMed ID: 8868452
[TBL] [Abstract][Full Text] [Related]
32. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study.
Bazarbachi A; Soriano V; Pawson R; Vallejo A; Moudgil T; Matutes E; Peries J; Molina A; de The H; Schulz TF; Catovsky D; Gill PS
Br J Haematol; 1997 Sep; 98(4):927-33. PubMed ID: 9326191
[TBL] [Abstract][Full Text] [Related]
33. Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sézary syndrome (SS).
Shalabi D; Bistline A; Alpdogan O; Kartan S; Mishra A; Porcu P; Nikbakht N
Chin Clin Oncol; 2019 Feb; 8(1):11. PubMed ID: 30691274
[TBL] [Abstract][Full Text] [Related]
34. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
35. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.
Delfau-Larue MH; Laroche L; Wechsler J; Lepage E; Lahet C; Asso-Bonnet M; Bagot M; Farcet JP
Blood; 2000 Nov; 96(9):2987-92. PubMed ID: 11049975
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
38. No evidence of HTLV-I infection in patients with mycosis fungoides and Sezary syndrome.
Pawlaczyk M; Filas V; Sobieska M; Gozdzicka-Józefiak A; Wiktorowicz K; Breborowicz J
Neoplasma; 2005; 52(1):52-5. PubMed ID: 15739027
[TBL] [Abstract][Full Text] [Related]
39. The role of human T cell lymphotropic virus type I tax in the development of cutaneous T cell lymphoma.
Zucker-Franklin D
Ann N Y Acad Sci; 2001 Sep; 941():86-96. PubMed ID: 11594585
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
